Published Online
on October 14, 2002

A more recent version of this article appeared on November 1, 2002

This Article Full Text (PDF) All Versions of this Article: 40/5/679    most recent 01.HYP.0000035706.28494.09v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by The Diabetes Prevention Program Research Group Search for Related Content PubMed PubMed Citation Articles by The Diabetes Prevention Program Research Group, Related Collections Other hypertension Glucose intolerance

Submitted on May 20, 2002
Revised on June 10, 2002

Hypertension, Insulin, and Proinsulin in Participants With Impaired Glucose Tolerance

The Diabetes Prevention Program Research Group

Abstract—The association of insulin resistance and hyperinsulinemia to blood pressure has remained controversial. We examined the association of insulinemia to hypertension and blood pressure using baseline measurements for participants of the Diabetes Prevention Program (DPP). The DPP is a multicenter randomized controlled trial of 3819 participants with impaired glucose tolerance, and is designed to evaluate interventions for the delay or prevention of type 2 diabetes. The relationship between hypertension and insulinemia is described overall and by ethnicity. The effects of demographics (age and gender), adiposity, and glucose on the relationship are also presented. Asian Americans and African Americans had a similarly high prevalence of hypertension as did whites; American Indians had a lower prevalence of hypertension. Among participants not on antihypertensive medications, systolic blood pressure was significantly (but weakly) correlated with fasting insulin (r=0.12), homeostasis model assessment of insulin resistance (HOMA IR; r=0.13), and fasting proinsulin (r=0.10) when adjusted for age and gender (all, P<0.001). Systolic blood pressure showed similar correlations to fasting insulin in each ethnic group. After further adjustment for body mass index, the association of fasting insulin to systolic and diastolic blood pressures weakened considerably but remained significant (systolic: r=0.06, P=0.002; DBP: r=0.06, P<0.001). We conclude that a weak but significant association between insulin, (and proinsulin and HOMA IR) and blood pressure exists but is largely explained by overall adiposity. This association is similar among ethnicities, with the possible exception of Hispanics. The relation between insulin concentrations and blood pressure explains relatively little of the ethnic differences in hypertensive prevalence.

Key words: insulin • insulin resistance • blood pressure • ethnicity • diabetes mellitus • obesity

This article has been cited by other articles:

				Diabetes Prevention Program Research Group Changes in Albumin Excretion in the Diabetes Prevention Program Diabetes Care, April 1, 2009; 32(4): 720 - 725. [Abstract] [Full Text] [PDF]

				A. Misra and L. Khurana Obesity and the Metabolic Syndrome in Developing Countries J. Clin. Endocrinol. Metab., November 1, 2008; 93(11_Supplement_1): s9 - s30. [Abstract] [Full Text] [PDF]

				A. F. Moore, K. A. Jablonski, J. B. McAteer, R. Saxena, T. I. Pollin, P. W. Franks, R. L. Hanson, A. R. Shuldiner, W. C. Knowler, D. Altshuler, et al. Extension of Type 2 Diabetes Genome-Wide Association Scan Results in the Diabetes Prevention Program Diabetes, September 1, 2008; 57(9): 2503 - 2510. [Abstract] [Full Text] [PDF]

				the Diabetes Prevention Program Research Group Lipid, Lipoproteins, C-Reactive Protein, and Hemostatic Factors at Baseline in the Diabetes Prevention Program Diabetes Care, October 1, 2005; 28(10): 2472 - 2479. [Abstract] [Full Text] [PDF]

				The Diabetes Prevention Program Research Group Impact of Intensive Lifestyle and Metformin Therapy on Cardiovascular Disease Risk Factors in the Diabetes Prevention Program Diabetes Care, April 1, 2005; 28(4): 888 - 894. [Abstract] [Full Text] [PDF]

				S. C. Smith Jr, L. T. Clark, R. S. Cooper, S. R. Daniels, S. K. Kumanyika, E. Ofili, M. A. Quinones, E. J. Sanchez, E. Saunders, and S. D. Tiukinhoy Discovering the Full Spectrum of Cardiovascular Disease: Minority Health Summit 2003: Report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group Circulation, March 15, 2005; 111(10): e134 - e139. [Full Text] [PDF]

				N. M. Punjabi, E. Shahar, S. Redline, D. J. Gottlieb, R. Givelber, and H. E. Resnick Sleep-Disordered Breathing, Glucose Intolerance, and Insulin Resistance: The Sleep Heart Health Study Am. J. Epidemiol., September 15, 2004; 160(6): 521 - 530. [Abstract] [Full Text] [PDF]